Results 151 to 160 of about 15,406 (277)

Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.

The Lancet Child & Adolescent Health, 2018
F. O'callaghan, S. Edwards, F. D. Alber, M. Cortina Borja, E. Hancock, A. Johnson, C. Kennedy, M. Likeman, A. Lux, M. Mackay, A. Mallick, R. Newton, M. Nolan, R. Pressler, D. Rating, B. Schmitt, C. Verity, J. Osborne   +17 more
semanticscholar   +1 more source

A Controlled Study of Oral Vigabatrin (ɣ-Vinyl GABA) in Patients with Cerebellar Ataxia [PDF]

, 1986
A. M. Bonnet, M. Esteguy, G. Tell, Paul J. Schechter, J. Hardenberg, Yves Agid   +5 more
openalex   +1 more source

Should you Use ACTH or Vigabatrin for Infantile Spasms? Or Why Not Use Both Together? [PDF]

, 2017
Prakash Kotagal
openalex   +1 more source

White matter spongiosis with vigabatrin therapy for infantile spasms

Epilepsia, 2018
P. Pearl, A. Poduri, S. Prabhu, C. Harini, R. Goldstein, Richard M Atkinson, D. Armstrong, H. Kinney   +7 more
semanticscholar   +1 more source

Vigabatrin, tiagabine, and visual fields [PDF]

, 2003
Mark Lawden
openalex   +1 more source

Risk of vigabatrin‐associated brain abnormalities on MRI in the treatment of infantile spasms is dose‐dependent

Epilepsia, 2017
Shaun A. Hussain, J. Tsao, Menglu Li, M. D. Schwarz, R. Zhou, Joyce Y. Wu, N. Salamon, R. Sankar   +7 more
semanticscholar   +1 more source

Effects of long term vigabatrin on somatosensory evoked potentials in epileptic patients. [PDF]

, 1989
Catherine Liégeois‐Chauvel, Patrick Marquis, D. Gisselbrecht, R. Pantieri, D Beaumont, Patrick Chauvel   +5 more
openalex   +1 more source

TREATMENT OF EPILEPSY IN TUBEROUS SCLEROSIS

Эпилепсия и пароксизмальные состояния, 2016
Epilepsy is the most frequent neurological sign of tuberous sclerosis complex (TSC) and it’s registered in 83.5% of patients. In majority of cases epilepsy begins during the first year of life (63%) and in 38.8% it’s manifesting as infantile spasms.
E. D. Belousova, M. Y. Dorofeeva, T. G. Ohapkina   +2 more
doaj  

Vigabatrin 35 years later - from mechanism of action to benefit-risk considerations [PDF]

, 2011
W. Donald Shields, John M. Pellock
openalex   +1 more source

Correction: A practical synthesis of enantiopure <i>syn</i>-β-amino-α-hydroxy acids from α-amino acids with application in the formal syntheses of l-TFB-TBOA and (<i>S</i>)-vigabatrin. [PDF]

RSC Adv
Long B, Zhang P, Jiang M, Guo P, Chen X, Shang S, Wu Z.   +6 more
europepmc   +1 more source